STATCenter·
STAT+: Argenx to buy Forte Biosciences for $2.2B
Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple autoimmune diseases.
Read at STAT →
Health · 1 sources covering this
STAT+: Argenx to buy Forte Biosciences for $2.2B
Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple autoimmune diseases.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/3b462eb0b531f4a7dc863a00252858ffbf178e7d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Argenx to buy Forte Biosciences for $2.2B"></iframe>
